Table 1 Pseudogene usage in GC events occurred at VH of L15H15 strains treated with TSA for 42 days

From: Streamlined human antibody generation and optimization by exploiting designed immunoglobulin loci in a B cell line

HC

CDR1

CDR2

CDR3

A12-3

A12-4

A12-5

B7-3

B7-9

B7-11

A12-3

A12-4

A12-5

B7-3

B7-9

B7-11

A12-3

A12-4

A12-5

B7-3

B7-9

B7-11

Total readsa

717

662

1176

981

994

1174

717

662

1176

981

994

1174

717

662

1176

981

994

1174

V

603

586

991

779

850

994

580

559

904

748

855

945

691

628

1119

894

946

1108

Full matchb

64

35

101

111

51

99

6

2

25

16

5

23

0

3

9

6

10

5

pVH001

0

0

0

2

0

1

0

0

0

0

0

0

0

0

0

0

0

0

pVH003

1

0

0

1

1

3

0

0

0

1

0

0

0

0

0

0

0

0

pVH005

0

1

0

0

1

3

0

0

0

1

0

0

0

0

2

0

0

0

pVH007

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

pVH009

3

4

7

1

1

1

0

0

0

0

0

0

0

0

0

0

0

0

pVH011

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1

0

0

0

pVH013

11

3

14

15

11

9

0

0

2

2

0

5

0

0

0

1

0

0

pVH015

25

14

57

29

14

33

0

1

1

2

0

3

0

0

0

0

0

0

pVH017

8

4

6

10

5

9

0

0

0

0

0

1

0

3

5

3

9

4

pVH019

0

1

2

1

0

0

0

1

2

0

1

0

0

0

0

1

0

1

pVH021

3

0

3

3

4

20

0

0

0

0

0

5

0

0

0

0

0

0

pVH023

12

6

10

49

13

18

6

0

19

10

3

8

0

0

0

0

0

0

pVH025

0

0

0

0

0

0

0

0

0

0

0

0

0

0

1

1

0

0

pVH027

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

pVH029

1

1

1

0

1

2

0

0

1

0

1

1

0

0

0

0

1

0

Partial matchc

16

11

18

47

23

26

19

12

34

25

19

33

7

9

14

7

5

18

  1. aThe total number of observed sequences in each library
  2. bThe number of sequences in which whole pseudogene sequences are copied
  3. cThe number of sequences not identical to any of initial V sequence or pseudogenes